CGN Nuclear Technology Development Co., Ltd.: history, ownership, mission, how it works & makes money

From its 1993 founding as China Dalian International Cooperation (Group) Holdings Ltd. to its 2017 rebirth as CGN Nuclear Technology Development Co., Ltd., this state-backed industrial player-58.89% owned by China General Nuclear Power Group-has evolved into a diversified operator spanning nuclear tech, irradiation services, plastics, real estate, ocean shipping and fisheries, with international projects totaling $1.7 billion in contracts and a strategic push into nuclear infrastructure marked by the 2025 start of the Zhaoyuan Nuclear Power Plant; the company reported 4,338 employees as of December 31, 2024 (a 4.64% year‑over‑year decline), invested over RMB 1 billion in R&D in 2022 (about 7% of revenue), and by December 22, 2025 traded at CNY 8.74 per share with a market capitalization of CNY 8.22 billion while posting a half‑year net loss of CNY 99.82 million for the period ended June 30, 2025-setting the stage for a deeper look at its history, ownership, mission, operations and revenue model.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): Intro

• Founded in 1993 as China Dalian International Cooperation (Group) Holdings Ltd.; rebranded to CGN Nuclear Technology Development Co., Ltd. in February 2017 to reflect a strategic focus on nuclear technology.
• 2014: expanded international footprint by establishing affiliates in Singapore, Suriname, Russia, Gabon, Guinea, Sierra Leone, Argentina, Spain, South Korea, and Japan.
• 2025: initiated construction of the Zhaoyuan Nuclear Power Plant in Shandong province, representing a major capital-and-technology investment in nuclear infrastructure.
• By December 31, 2024, headcount stood at 4,338 employees (a 4.64% decrease vs. prior year), reflecting workforce optimization and efficiency measures.

• Subsidiary-level relationship to the China General Nuclear Power Group (CGN) industrial system, operating within a state-linked energy and engineering ecosystem.
• Listed on the Shenzhen Stock Exchange (000881.SZ), public float accessible to institutional and retail investors; market capitalization on December 22, 2025: CNY 8.22 billion.
• Share price on December 22, 2025: CNY 8.74 per share.

• Mission: enable safe, scalable nuclear technology deployment and related industrial services across domestic and international markets.
• Strategic pillars: nuclear technology development, engineering procurement and construction (EPC) support, and diversification into complementary businesses (ocean transportation, fisheries, real estate) to stabilize cash flow and leverage asset base.
• Details on corporate mission and values: Mission Statement, Vision, & Core Values (2026) of CGN Nuclear Technology Development Co., Ltd.

• Nuclear technology R&D and integration: design support, component supply, technical consulting for nuclear power plants and fuel-cycle adjacent projects.
• Project delivery: participation in EPC consortia, site construction management (e.g., Zhaoyuan Nuclear Power Plant), and operational handover support.
• International operations: local affiliates provide market entry, logistics, and project support across multiple continents established since 2014.
• Supporting industries: ocean transportation and fisheries provide logistics, offshore service revenue, and asset utilisation; real estate provides recurring income and collateral value.

• Contract revenue from nuclear engineering, procurement and construction (EPC) and technology services.
• Long-term service contracts and O&M support for nuclear facilities (consulting, spare parts, lifecycle upgrades).
• Asset-backed income from diversified operations: ocean transport charters, fisheries product sales, and real estate leasing/development.
• Investment returns and project-finance fees on joint ventures and international affiliates.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): History

• Parent: China General Nuclear Power Group (CGN), a central state-owned enterprise under SASAC.
• Major shareholder (Dec 2023): CGN holds a 58.89% stake, giving it controlling interest and strategic direction.
• Public listing: Shares traded on the Shenzhen Stock Exchange under ticker 000881.SZ, providing liquidity and access to capital markets.
• Business diversification: Core nuclear-related technology & services plus ocean transportation and property development for recurring revenue.

• How ownership drives the business: The CGN controlling stake enables preferential access to nuclear project contracts, technology transfer and group-level capital support.
• Revenue stability: Diversified operations (ocean transport, real estate) smooth cash flow volatility inherent to project-driven nuclear contracts.
• Growth levers: Leverage of CGN's domestic and international nuclear expansion plans, plus monetization of non-core assets.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): Ownership Structure

• Mission: To lead in nuclear technology innovation with a focus on reactor safety, operational efficiency, and advanced nuclear fuel recycling technologies.
• Work culture: Adopts a 'strict, prudent, careful, and practical' operational ethos to maintain high technical and safety standards.
• Environmental commitment: Provides electron beam treatment for specialty wastes, advanced wastewater treatment technologies, and other services that reduce nuclear-cycle environmental impact.
• R&D focus: Invested over RMB 1 billion in R&D in 2022, representing about 7% of 2022 revenue, underlining priority on technological advancement and product development.
• International expansion: Pursues projects across Asia, Europe, and Africa to support nuclear capability development in emerging markets.
• Strategic partnerships: Seeks collaborations that promote safe, sustainable nuclear energy practices globally.

• Major controlling shareholder: China General Nuclear Power Group (state-owned), which holds the single largest controlling stake and strategic control over company direction.
• Other significant holders: CGN Power (group affiliates), state-related investment vehicles, institutional investors and domestic retail/public float.
• Governance orientation: State-backed majority ownership combined with public listing governance and institutional investor oversight.

• Engineering, procurement and construction (EPC) and consulting for nuclear projects - contract revenues from domestic and overseas plants.
• Technology licensing and equipment sales - specialized reactor components, fuel cycle equipment, and electron-beam treatment systems.
• Service contracts - long-term operations & maintenance, waste-treatment and environmental remediation services.
• R&D-driven product commercialization - spin-outs and licensed technologies derived from in-house R&D investments.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): Mission and Values

• Cable materials and advanced polymers - production and sale of specialty plastics including modified polycarbonate, polyester and polypropylene for industrial uses and for cable insulation.
• Electron-beam accelerators and industrial irradiation - design, manufacture and deployment of electron accelerators used for material modification, sterilization and waste treatment.
• Irradiation processing and environmental services - electron beam treatment of specialty hazardous waste, antibiotic-residue degradation, pharmaceutical wastewater treatment, and medical sewage and solid-waste disposal services.
• Nuclear environmental protection - services and technologies to monitor and remediate radio-contaminated sites and to provide environmental safeguards for nuclear facilities.
• New energy and elastomer materials - supplying components and specialty elastomers for renewable energy applications and energy infrastructure.
• Plastics production, real estate and construction - manufacturing commodity plastics, property development and construction project delivery, often tied to infrastructure contracts abroad.
• Maritime shipping, ship investment and fishery - ocean shipping operations, maritime cargo transportation, ship chartering and investments in shipping assets supporting the company's international project logistics.

• Equipment sales: one-time capital sales of electron accelerators, irradiation lines and polymer production equipment to industrial customers and municipal operators.
• Processing fees: recurring treatment fees for pharmaceutical wastewater, medical waste, antibiotic-residue destruction and sterilization services charged per volume or per batch.
• Materials sales: recurring income from polymers, cable materials and elastomers sold to domestic and export markets.
• Project contracting and EPC: milestone-based construction revenue from domestic and international infrastructure projects (roads, housing, hospitals), often supported by long-term contracts and performance guarantees.
• Shipping and asset leasing: charter income and freight revenue from maritime operations; yield from ship investments and charters.

• In-house electron-beam and accelerator engineering allowing turnkey irradiation solutions (equipment + process + service).
• Integrated waste-treatment chains: screening, irradiation/oxidation, biological/chemical polishing and safe disposal - enabling regulated medical and pharmaceutical waste handling.
• Material science capability to produce modified polymers and elastomers for niche industrial applications, improving margin over commodity plastics.
• Project execution experience in emerging markets - international EPC footprint with risk diversification via multiple geographies and contract types.

• Revenue concentration: EPC project recognition and overseas project timing create year-to-year volatility depending on contract close and progress billing.
• Regulatory exposure: medical and pharmaceutical waste treatment and nuclear-environment services are tightly regulated; compliance is central to operations and market access.
• Technology dependency: continued innovation in electron-beam and wastewater technologies is required to maintain differentiation versus chemical or biological alternatives.
• Geopolitical/project risk: international construction and infrastructure projects expose the company to cross-border financing, local regulation and execution risks.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): How It Works

• Manufacturing & sales: specialty cable materials (radiation-resistant power and instrumentation cables) and industrial electron accelerators for sterilization, crosslinking and materials modification.
• Irradiation processing services: contract EB irradiation of medical devices, packaging, agricultural products and specialty waste; electron-beam treatment of industrial wastewater and off-gases for pollution control.
• New energy & advanced materials: production and R&D of synthetic polymers, radiation-modified polymers and components for energy storage and next-generation materials.
• Diversified operations: real estate development, ocean transportation and fisheries to provide non-cyclical cash flows and asset diversification.
• International contracting: EPC and supply contracts (e.g., overseas roadworks and hospital projects) that expand revenue base and technical footprint.

• Product sales: direct sales of cables, accelerators and synthetic materials to utilities, manufacturers and healthcare firms.
• Service contracts: fee-for-service irradiation treatments and turnkey wastewater/solid-waste remediation projects.
• Project-based EPC income: construction and equipment supply for domestic and overseas infrastructure (roads, hospitals, industrial plants).
• Licensing & technology transfer: proprietary radiation-processing know-how monetized via partnerships and maintenance/service contracts.
• Real asset income: rental, sales and operations from real estate, shipping charters and aquaculture sales.

• Estimated total revenue (FY2023): ~RMB 1.7-2.0 billion, driven by accelerating demand for irradiation services and cable orders tied to nuclear maintenance cycles.
• Gross margin profile: manufacturing and accelerators typically deliver higher margins (mid-teens to low-20%); service and EPC margins vary by contract size and geography.
• Installed EB capacity: dozens of medium-to-high energy accelerators across plants and service centers-enabling throughput for medical device sterilization and waste treatment at scale.
• R&D & capex intensity: sustained R&D spending (several percent of revenue) focused on radiation applications, polymer science and accelerator efficiency improvements.
• International contract contributions: single overseas EPC projects (e.g., roadworks in Suriname, hospital build in Saudi Arabia) can represent multi-million RMB contract values and multi-year revenue recognition.

• Affiliation with China's state-owned nuclear groups-preferred supplier status for nuclear cable materials and radiation technologies, easing contract access and financing.
• Proprietary radiation-processing know-how-barriers to entry in electron-beam treatment and nuclear-grade materials.
• Diversification across product sales, recurring irradiation services and asset-backed businesses-reduces single-market volatility.
• Export and EPC capability-captures higher-margin project revenues and supports technology commercialization overseas.

CGN Nuclear Technology Development Co., Ltd. (000881.SZ): How It Makes Money

• Core nuclear technology services: licensing, fuel cycle support, engineering consulting and equipment supply for reactor projects.
• Construction & project development: EPC and project management for domestic and international nuclear power and ancillary facilities.
• Marine and ocean businesses: ocean transportation and fisheries operations that provide non-nuclear recurring cash flow.
• Real estate development: monetization of land and property assets to support balance-sheet liquidity.
• International project development: turnkey and advisory work in Asia, Europe and Africa focused on emerging-market nuclear capacity building.

• Near-term challenges: the H1 2025 net loss and capital intensity of nuclear projects.
• Opportunities: continued domestic nuclear build-out, export demand in developing markets, and monetization of non-core assets.
• Strategic aim: expand international footprint with projects in Asia, Europe and Africa to capture emerging-market nuclear demand.